Why insider trading matters?
What separates FormWhispers.com from others is that we created it to meet our own needs and we use it everyday to make better investment decisions. We will keep improving it to serve us better and to serve you better.
Quanterix Corporation, a life sciences company, develops and markets digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific. The company offers HD-X instrument, a sensitive automated multiplex protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection technology in various applications, including direct detection of nucleic acids. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.
| Trade Date | Insider | Title | Buy/Sell | #Shares | Price | Value | Option |
|---|---|---|---|---|---|---|---|
| 2022-08-01 | Toloue Masoud | President & CEO | Sell | 446 | $15.61 | $6,964 | No |
| 2022-08-01 | DOYLE MICHAEL A | CFO and Treasurer | Sell | 471 | $17.96 | $8,457 | No |
| 2022-08-01 | Fry John J | General Counsel & Secretary | Sell | 401 | $15.61 | $6,261 | No |
| 2022-07-05 | HRUSOVSKY E KEVIN | Executive Chairman | Sell | 960 | $16.57 | $15,906 | No |
| 2022-07-05 | Fry John J | General Counsel & Secretary | Sell | 387 | $16.57 | $6,412 | No |
| 2022-06-02 | Fry John J | General Counsel & Secretary | Sell | 378 | $17.47 | $6,605 | No |
| 2022-05-02 | HRUSOVSKY E KEVIN | Executive Chairman | Sell | 649 | $22.36 | $14,515 | No |
| 2022-05-02 | Fry John J | General Counsel & Secretary | Sell | 429 | $22.36 | $9,595 | No |
| 2022-04-01 | HRUSOVSKY E KEVIN | Chairman and CEO | Sell | 868 | $29.79 | $25,860 | No |
| 2022-04-01 | Roskey Mark T. | SVP, Strategic Partnerships | Sell | 171 | $29.79 | $5,095 | No |
| 2022-04-01 | Fry John J | General Counsel & Secretary | Sell | 524 | $29.79 | $15,611 | No |
| 2022-03-23 | Duffy David C. | SVP R&D and CTO | Sell | 3,266 | $30.00 | $97,980 | No |
| 2022-03-01 | Roskey Mark T. | SVP, Strategic Partnerships | Sell | 166 | $31.46 | $5,222 | No |
| 2022-03-01 | HRUSOVSKY E KEVIN | Chairman and CEO | Sell | 589 | $31.46 | $18,530 | No |
| 2022-03-01 | Fry John J | General Counsel & Secretary | Sell | 371 | $31.46 | $11,671 | No |
| 2022-03-01 | Mattoon Dawn | Sr. VP, Diagnostics | Sell | 267 | $31.46 | $8,399 | No |
| 2022-02-09 | Fry John J | General Counsel & Secretary | Sell | 481 | $34.97 | $16,820 | No |
| 2022-02-09 | Mattoon Dawn | Sr. VP, Diagnostics | Sell | 318 | $34.97 | $11,120 | No |
| 2022-02-09 | HRUSOVSKY E KEVIN | Chairman and CEO | Sell | 1,364 | $34.97 | $47,697 | No |
| 2022-02-04 | Duffy David C. | SVP R&D and CTO | Sell | 3,266 | $30.91 | $100,952 | No |
| 2022-02-02 | Roskey Mark T. | SVP, Strategic Partnerships | Sell | 166 | $31.46 | $5,222 | No |
| 2022-02-02 | Mattoon Dawn | Sr. VP, Diagnostics | Sell | 267 | $31.46 | $8,399 | No |
| 2022-02-02 | HRUSOVSKY E KEVIN | Chairman and CEO | Sell | 589 | $31.46 | $18,530 | No |
| 2022-02-02 | Fry John J | General Counsel & Secretary | Sell | 371 | $31.46 | $11,671 | No |
| 2022-01-31 | Duffy David C. | SVP R&D and CTO | Sell | 3,266 | $30.00 | $97,980 | No |
| 2022-01-03 | HRUSOVSKY E KEVIN | Chairman and CEO | Sell | 3,715 | $41.91 | $155,683 | No |
| 2021-12-29 | Duffy David C. | SVP R&D and CTO | Sell | 1,667 | $40.71 | $67,864 | No |
| 2021-12-01 | HRUSOVSKY E KEVIN | Chairman and CEO | Sell | 3,710 | $40.29 | $149,477 | No |
| 2021-12-01 | Roskey Mark T. | SVP, Strategic Partnerships | Sell | 147 | $40.29 | $5,923 | No |
| 2021-12-01 | Mattoon Dawn | Sr. VP, Diagnostics | Sell | 353 | $40.29 | $14,222 | No |
Insider Smart
Insider Smart